Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome

about

Prognostic Impact of IPSS-R and Chromosomal Translocations in 751 Korean Patients with Primary Myelodysplastic Syndrome

Item

http://www.wikidata.org/entity/Q36185741

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Prognostic Impact of IPSS-R an ...... imary Myelodysplastic Syndrome

@ast

Prognostic Impact of IPSS-R an ...... imary Myelodysplastic Syndrome

@en

type

Item

label

Prognostic Impact of IPSS-R an ...... imary Myelodysplastic Syndrome

@ast

Prognostic Impact of IPSS-R an ...... imary Myelodysplastic Syndrome

@en

prefLabel

Prognostic Impact of IPSS-R an ...... imary Myelodysplastic Syndrome

@ast

Prognostic Impact of IPSS-R an ...... imary Myelodysplastic Syndrome

@en

P1476

Prognostic Impact of IPSS-R an ...... imary Myelodysplastic Syndrome

@en

P2093

Byung-Soo Kim

http://www.w3.org/2001/XMLSchema#string

Chu-Myoung Seong

http://www.w3.org/2001/XMLSchema#string

Dong-Yeop Shin

http://www.w3.org/2001/XMLSchema#string

Hong Ghi Lee

http://www.w3.org/2001/XMLSchema#string

Hyeoung-Joon Kim

http://www.w3.org/2001/XMLSchema#string

Inho Kim

http://www.w3.org/2001/XMLSchema#string

Jae Hoon Lee

http://www.w3.org/2001/XMLSchema#string

Jae-Sook Ahn

http://www.w3.org/2001/XMLSchema#string

Jeong-Ok Lee

http://www.w3.org/2001/XMLSchema#string

Jinny Park

http://www.w3.org/2001/XMLSchema#string

P2860

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts

Proposals for the classification of the myelodysplastic syndromes

Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study

International scoring system for evaluating prognosis in myelodysplastic syndromes

Frequent pathway mutations of splicing machinery in myelodysplasia

TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients

Revised international prognostic scoring system for myelodysplastic syndromes.

Clonal diversity of recurrently mutated genes in myelodysplastic syndromes.

P304

e0166245

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0166245

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-11-08T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27824923

http://www.w3.org/2001/XMLSchema#string

P932

5100959

http://www.w3.org/2001/XMLSchema#string